Navigation Links
Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
Date:7/25/2012

lization of chemotherapy can eliminate the need for late-stage, extended therapies.

"We see an opportunity in lung cancer to change the treatment paradigm with more effective diagnostics," said Gregory T. Lucier, chairman and chief executive officer of Life Technologies.  "As Life Technologies moves further into the diagnostics space, we will focus on tests that have strong clinical utility where there is a large unmet need."

Life Technologies Possesses Breadth of Platforms with Diagnostic Potential

Life Technologies possesses a breadth of platforms that can be leveraged in the development of new diagnostics, including next-generation sequencing, Sanger sequencing, qPCR and proteomics.  The company is actively working to drive the development of diagnostic content across multiple platforms, as evidenced by a companion diagnostic agreement with GlaxoSmithKline, a test development partnership with Gen-Probe, and recently announced collaborations with Boston Children's Hospital and the Hospital for Sick Children in Toronto, to develop the company's next-generation sequencers for clinical research in pediatric diseases.

"Since the test was developed and will be run in the Pinpoint laboratory on Life's qPCR platform, in addition to offering an LDT in the United States, we will be able to leverage our existing global installed qPCR platforms, which are currently being utilized in a significant number of clinical labs outside of this country," said Andrews.  "Life Technologies intends to pursue In Vitro Diagnostic certification outside of the United States, so the test can be broadly deployed on the company's regulated platforms including the 7500 Fast Dx for qPCR."

Life Technol
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Life Technologies and SATuRN Collaborate to Increase Access to HIV Testing in Africa
2. Life Technologies Develops Simplified SAME-DAY STEC Solution for Detecting Multiple Strains of E. coli in Ground Beef
3. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
4. Lifeline Biotechnologies First Warning Systems
5. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
6. Acquisition of Navigenics Expands Life Technologies Capabilities in Diagnostics
7. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
8. Dehaier Medical Receives Software Copyrights for Four Proprietary Technologies
9. CSS Health Technologies Hires Industry Leader as New Senior Vice President of Sales
10. Ancor and Merit acquire Uplift Technologies for Carex Health Brands
11. Ultra Clean Holdings, Inc. Completes Strategic Merger with Advanced Integration Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/17/2014)... Scientists have identified the first genetic variant specifically ... sub-type accounting for around 10-15 per cent of ... study of the breast cancer sub-type, called invasive ... genetic causes of this particular kind of breast ... The research, published today (Thursday) in the journal ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study recalculates costs of combination vaccines 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2
... Bill Germanakos to Deliver NBGH Keynote Address, ... DGX ), the leading provider of diagnostic ... Business Group,on Health (NBGH), an association of more ... Best Employers for Healthy Lifestyles Gold Award to ...
... with seizures, SEATTLE, May 13 The Epilepsy ... in,Seattle, Spokane and Portland. The events will occur on ... Spokane at Riverfront Park. The following,day, Sunday, June 22, ... take place from 9:30 am-12:00 pm., "Everyone is ...
... 13 The Board of Directors of,MSA (NYSE: MSA ... per,share on common stock, payable June 10, 2008 to shareholders ... a dividend of 56-1/4 cents per share on,preferred stock, payable ... About MSA:, Established in 1914, MSA is a ...
... tobacco smoke respond particularly well to montelukast (Singulair) ... Research Center. Associate Professor of Pediatrics Nathan ... biomarkers that may help physicians predict even more ... These findings will help doctors know in advance ...
... Center,for Adoption announces a $10,000 grant from the Aetna ... during pregnancy., Kimberlee Walters-Sanders, an Aetna sales representative ... Head of Sales, will,present the award to Gladney staff ... Gladney,s campus, located at 6300 John Ryan Dr., Fort,Worth., ...
... Both Proposals -, LAKE FOREST, Ill., May 13 ... specialty pharmaceutical and medication,delivery company, today held its 2008 ... votes on two proposals and a brief,update on the ... to the success of our strategies of investing,for growth, ...
Cached Medicine News:Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 2Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 3Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 4Health News:Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles' 5Health News:Girls and children exposed to tobacco smoke benefit more from montelukast (singulair) 2Health News:Gladney Center for Adoption Receives Whole Health Grant from Aetna Foundation 2Health News:Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders 2
Bone Curette, 180 mm...
Endocrette Endocervical Curette is a stainless-steel curette with closed blade....
Townsend is a endocervical stainless-steel curette with round tapered tip....
Kevorkian Endocervical Curette is a stainless-steel curette with a basket. It is narrow tipped for sampling without dilation....
Medicine Products: